EMSA analysis also revealed that A549- and CL1-5-CM increased the DNA binding activity of STAT3, and laricitrin reduced the lung cancer-induced enhancement of STAT3 on DNA binding capacity in CD14+ monocytes (Figure 5C). Here, STAT3 is linked to lung carcinoma.